Association of the time in targeted blood glucose range of 140 to 180 mg/dL with the mortality of critically ill patients with diabetes: analysis of the MIMIC-IV database [0.03%]
血糖水平在140~180毫克/分升目标范围内的每一点时间与危重症糖尿病患者死亡率之间的关联：来自主观四代数据库的分析
Huimin Ye,Zilan Ma,Qunchuan Zong et al.
Huimin Ye et al.
Background: Time in range (TIR), a glycemic control metric, is increasingly linked to diabetes outcomes. A target of 140-180 mg/dL is recommended for critically ill hyperglycemic patients. ...
DiaBar: Predicting type 2 diabetes remission post-metabolic surgery utilizing mRNA expression profiles from subcutaneous adipose tissue [0.03%]
基于皮下脂肪组织的mRNA表达谱预测代谢手术后2型糖尿病缓解的DiaBar模型
Jonas Wagner,Manfred Wischnewsky,Patricia von Kroge et al.
Jonas Wagner et al.
Background: Subcutaneous adipose tissue (SAT) is a metabolic organ, which is involved in the pathogenesis of type 2 diabetes (T2D). Methods to predict diabetes remission after metabolic surgery exist, however their predic...
Mild hyperprolactinemia in women with polycystic ovary syndrome. Insights from a large cross-sectional study [0.03%]
多囊卵巢综合征女性轻度高催乳素血症的患病率及临床特征：一项大型横断面研究的新发现
Manuel Luque-Ramírez,Alejandra Quintero-Tobar,María Ángeles Martínez-García et al.
Manuel Luque-Ramírez et al.
Background: Hyperprolactinemia is an exclusion criterion for polycystic ovary syndrome (PCOS), albeit PCOS itself is argued to induce mild hyperprolactinemia. We aimed to study the prevalence and causes of hyperprolactine...
Enrollment in a fracture liaison service does not guarantee post fracture follow-up [0.03%]
骨折联络服务的注册并不能保证术后随访
Craig R Jenkins,Jessica D Collier,Claire I Yee et al.
Craig R Jenkins et al.
Objective: To assess post fracture outpatient follow-up adherence in a cohort of patients enrolled in a fracture liaison service (FLS). Methods: ...
Collagen in pituitary adenomas: A comprehensive review of biological roles and clinical implications [0.03%]
垂体腺瘤中的胶原蛋白：生物学作用和临床意义的全面回顾
Jie Liu,Yong Yao,Lian Duan et al.
Jie Liu et al.
Pituitary adenomas (PAs) are common brain tumors, accounting for about 15% of all brain neoplasms. Although generally benign, they can lead to serious complications through mass effects and hormone dysregulation. Emerging evidence suggests ...
Decreased insulin dose-adjusted hemoglobin A1c in adults with cystic fibrosis-related diabetes treated with elexacaftor-tezacaftor-ivacaftor [0.03%]
经艾沙卡弗托--tezacaftor-ivacaftor治疗的囊性纤维化相关糖尿病成人患者的校正胰岛素剂量的血红蛋白A1c降低
Espérie Burnet,Deborah Grunewald,Etienne Larger et al.
Espérie Burnet et al.
Background: Elexacaftor-tezacaftor-ivacaftor (ETI) became available for adults with cystic fibrosis (CF) in 2019, but its impact on CF-related diabetes (CFRD) remains unclear. ...
Cell division cycle 20 promotes tumor progression and predicts poor clinical outcome in childhood and adult adrenocortical carcinoma [0.03%]
细胞分裂周期20促进肾上腺皮质癌的进展并预示不良临床结局
Jiahong Chen,Peisheng Huang,Yongcheng Shi et al.
Jiahong Chen et al.
Background: Adrenocortical carcinoma (ACC) is an uncommon and highly aggressive tumor with a grim prognosis. Numerous investigations have elucidated a close association between the dysregulated expression of multiple gene...
Elevated glucose levels in melanoma patients - a real-world analysis [0.03%]
黑色素瘤患者的高血糖水平-一项现实世界的研究分析
Joan Walter,Bojan Bojanic,Manuel Dittli et al.
Joan Walter et al.
Aim: To assess the glycemic status of consecutive melanoma patients undergoing standardized capillary fasting blood glucose (cFBG) assessment prior to fluorodeoxyglucose positron emission tomography/computed tomography (F...
Predicting accelerated fetal growth in pregnancy: beyond maternal hyperglycemia - The role of prothymosin-α, inflammatory cytokines, and angiogenic factors [0.03%]
预测妊娠期胎儿加速生长：超越母体高血糖——胸腺素-α、炎症细胞因子和血管生成因子的作用
Maria Mirabelli,Marta Greco,Stefano Iuliano et al.
Maria Mirabelli et al.
Aim: This study investigates prothymosin-α (ProT-α), an immunomodulatory protein, as a potential biomarker for insulin resistance in gestational diabetes (GDM), and as a predictor of fetal growth by 20 weeks of gestation (wg). Methods: Fo...
SGLT2 inhibitor therapy in overweight and obese patients with cystic fibrosis-related diabetes: Case series [0.03%]
囊性纤维化相关糖尿病的肥胖患者的SGLT2抑制剂治疗：病例系列研究报告
Ammar Ahmed,Roshini Asirvatham,Jagdeesh Ullal et al.
Ammar Ahmed et al.
Cystic fibrosis-related diabetes (CFRD) is the most prevalent extrapulmonary comorbidity in CF. While insulin remains the standard treatment, increasing rates of overweight and obesity due to CFTR modulators highlight the need for new thera...